Navigation Links
GenTel gets federal grant to develop allergy test

Madison, Wis. - GenTel BioSciences, Inc., a developer of protein chip technologies, has received a $1.2 million Phase II SBIR grant from the National Institutes of Health to develop a test that promises less painful diagnosis of respiratory allergies.

An estimated 50 million Americans suffer from mild to chronic seasonal allergies, and current d......

Full article >>> rovide sizeable amounts of blood and have a slow turnaround time for results, so a small prick of the finger involved in the new test is preferred over both existing methods.

Vodenlich said the company's biochips provide a more qualitative and quantitative way to measure how allergic patients are to certain allergens, which would be a leap forward in allergy diagnosis. GenTel has the all......

Full article >>> A key collaborator on the allergy project is Dr. Robert K. Bush, a professor of medicine at University of Wisconsin-Madison School of Medicine and Public Health. "What our company is all about right now is developing biochip tests that are going to be used in research," Vodenlich said. "The nice thing about the allergy chip is that it will first be used in research and validated by allergists like......

Full article >>>
'"/>

Source:wistechnology.com By Joe Vanden Plas 05/22/06


Related biology technology :

1. GenTel acquires GlaxoSmithKline chip platform
2. New angel capital centered on GenTel agreement with big pharma
3. GenTel licenses next generation cancer research
4. GenTel to distribute cancer research tool
5. Madisons GenTel partners with Taiwan firm
6. Fisher Biosciences contracts with Madison-based GenTel BioSurfaces
7. GenTel BioSurfaces launches new assay platform
8. GenTel will sell Dutch firms biomolecule labeling technology
9. Bone Care, GenTel, MyWeather
10. GenTel receives $250,000 state loan
11. GenTel claims $900,000 in federal grants this year for biochip research
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/8/2016)... , February 8, 2016 ... Oncology Private Limited, an innovation-driven oncology company developing ... and less toxic, today announced that chairman emeritus ... has invested in the company as part of ... round, joining existing investors Navam Capital and Aarin ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... ... a wide range of loose, bulk foods at various stages of the production ... also used to inspect large bulk products post packaging such as sacks of ...
(Date:2/8/2016)... 2016 --> ... "Company"), the ultra-rapid Point-Of-Care (POC) molecular diagnostics company, today announces ... trachomatis (CT) test to be launched on the Company,s io® ... the CT test is now cleared for sale within the ... The launch of the io® CT test signals a new ...
(Date:2/5/2016)... SAN DIEGO , Feb. 5, 2016 ... the region,s trusted information source for community, health and ... San Diego) will integrate to enhance care coordination ... people to the services they need and to better ... to improve care.   San Diego ...
Breaking Biology Technology:
(Date:2/5/2016)... 5, 2016 http://www.researchandmarkets.com/research/5kvw8m/global_facial ... "Global Facial Recognition Market 2016-2020" ... http://www.researchandmarkets.com/research/5kvw8m/global_facial ) has announced the addition of ... report to their offering. --> ... has announced the addition of the ...
(Date:2/3/2016)... LIVERMORE, Calif. , Feb. 3, 2016 ... Police Department in Missouri ... of license plate reader (LPR) data from Vigilant Solutions. ... a hit-and-run case in which the victim was walking out ... a parking space next to his vehicle, striking his ...
(Date:2/2/2016)... 2016 Checkpoint Inhibitors for Cancer – ... Are you interested in the future of cancer ... inhibitors. Visiongain,s report gives those predictions to 2026 ... level. Avoid falling behind in data or ... revenues those emerging cancer therapies can achieve. There ...
Breaking Biology News(10 mins):